Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02284
Species: Homo sapiens
Position : chr1:214150511-214151337
Year: 2015
Title: GATA2 is required for lymphatic vessel valve development and maintenance.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Lymphedema
PMID:  26214525
MONDO: MONDO:0019297
Tissue: lymphatic vessel
Tissue Ontology ID: UBERON:0001473
Cell Source: K-562
CVCL ID: CVCL_0004
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Disease-associated enhancer analysis
High Throughput Method: ChIP-seq
Low Throughput Method: Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP
About Target Gene
Target gene : PROX1
About TF
TF name : FOXC2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 11 found
Enhancer ID Position Tissue Cell Disease
E_02200 chr1:214150511-214151337 dermis endothelial cell lymphedema
E_02271 chr1:214150511-214151337 dermis endothelial cell lymphedema
E_02272 chr1:214150511-214151337 dermis endothelial cell lymphedema
E_02285 chr1:214150511-214151337 lymphatic vessel NA Lymphedema
E_02286 chr1:214150511-214151337 lymphatic vessel NA Lymphedema
E_02266 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02273 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02274 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02275 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02276 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02277 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
Expression of Target Genes for the Enhancer